Jul 2026
EV30 suppresses choroidal neovascularization associated with modulation of the mTOR/NF-κB/p38 MAPK signaling pathway.
Evaluated therapeutic efficacy and mechanism of EV30, a novel pterostilbene derivative, in suppressing CNV suggest that EV30 represents a potential therapeutic candidate for CNV by suppressing pathological angiogenesis and modulating inflammation-associated signaling pathways.
Songyu Xu, Qiao Zhuo, Jing Li et al.
· Microvascular Research · 0 citations